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Purpose: To analyze the long-term outcomes of intracorneal ring segments (ICRS) implanta-
tion for keratoconus management in pediatric patients.
Methods: Retrospective case series review of the long-term (>5 years) outcomes of Intacs® ICRS 
implantation for keratoconus in pediatric patients (age <18 years old at the time of surgery) between 
January 2008 and December 2011 at Ophthalmology Department of Hospital de Santo António. 
Demographic data, follow-up time, preoperative and postoperative uncorrected visual acuity (UCVA) 
and best-corrected visual acuity (BCVA) in decimal scale, and corneal topography were evaluated. 
Statistical analysis was done using SPSS for windows (version 24). Significance was set at p<0.0125.
Results: Fourteen eyes of 14 patients, with a mean age of 15.36 years (range 10–18 years), 
were included in this study. All patients had been diagnosed with keratoconus with reported 
progression in the 6 months prior to surgery. Follow-up time was 6.36±0.97 years. UCVA and 
BCVA improved after ICRS implantation (p<0.0125). Keratometry (K) minimum (Kmin) and 
K maximum (Kmax) decreased after surgery (p<0.0125). During follow-up, UCVA, BCVA, 
Kmin, and Kmax values ranged, showing a tendency to worsen at the end of follow-up. However, 
statistically significant differences were not observed.
Conclusion: ICRS implantation showed good visual and topographic results in pediatric 
patients. Long-term follow-up suggests that, despite ICRS implantation, there is still progres-
sion of keratoconus. To the best of our knowledge, there are no reports regarding the long-term 
efficacy of ICRS implantation in pediatric patients.
Keywords: intracorneal ring segments, keratoconus, pediatric patients
Introduction
Classically, keratoconus is a bilateral, corneal, ectatic noninflammatory condition, 
the hallmark of which is progressive corneal steepening and thinning,1 which leads to 
irregular astigmatism and secondary loss of best-corrected visual acuity (BCVA). The 
onset of keratoconus is common during the second decade of life, with great variability 
in progression, which may last until the third or fourth decade of life.2 Keratoconus 
behaves differently in pediatric patients, presenting a more aggressive course in this 
age group. There is no gender predominance; however, affected younger patients are 
more often males.3
The treatment for keratoconus should be personalized, depending on the sever-
ity of disease, the amount of vision loss, the progression rate, and the psychosocial 
aspect of the patient. The therapeutic options can vary from eyeglasses and contact 
lenses to intracorneal ring segments (ICRS) implantation, corneal transplantation, 
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and cross-linking associated or not with photorefractive 
keratectomy.4 The traditional conservative management of 
keratoconus begins with eyeglasses correction and contact 
lenses.5,6 When vision can no longer be corrected with 
eyeglasses and/or contact lenses, surgical options should 
be considered.1 ICRS are small devices of synthetic mate-
rial which can be used to reshape the abnormal cornea, 
inducing a geometric change of central curvature. This 
leads to an improvement in topographic abnormalities, 
reducing refractive error, and improving visual acuity.6,7 
Classically, the goal of segment implantation is to delay or 
avoid corneal grafts.8 There are many types of ICRS devices. 
Intacs® (Addition Technology Inc., Fremont, CA, USA) are 
semicircular pieces of polymethyl methacrylate (PMMA) 
with fixed outer diameter and width, available in different 
thicknesses. There is an additional Intacs design named 
severe keratoconus (SK) designed with rounded edges to 
potentially reduce the incidence of visual symptoms. Fer-
rara® and Keraring® are other types of ICRS commonly 
used to treat corneal ectatic diseases.
Many studies report the efficacy of ICRS implantation in 
the treatment of keratoconus, including long-term follow-up 
(superior to 5 years).9–13 Some studies suggested that this 
surgical treatment has the potential to halt the progression of 
keratoconus, but there is still no definitive scientific evidence 
to confirm that.11–13
To the best of our knowledge, there are no reports regard-
ing the long-term efficacy of ICRS implantation in pediatric 
patients. The purpose of this study is to report long-term 
follow-up of ICRS implantation in pediatric population in 
the management of keratoconus.
Methods
Retrospective review of the medical records of patients with 
keratoconus submitted for ICRS implantation in pediatric 
patients, between January 2008 and December 2011, to 
Ophthalmology Department of Centro Hospitalar do Porto, 
Oporto, Portugal, was performed. This study included only 
patients who completed at least 5 years of follow-up. Patients 
were excluded from ICRS implantation if any of the following 
criteria was present: advanced keratoconus with curvatures 
>60.0 diopters (D) and significant apical opacities or scaring, 
previous hydrops, corneal thickness <400 μm in the planned 
site of ICRS implantation, and intense atopia. These are the 
criteria used, in our department, to define candidates not 
suitable for ICRS implantation. When both eyes of the same 
patient met the inclusion criteria, it was decided to include 
only one eye for statistical analysis. In these cases, we chose 
to randomly select one of the eyes as recommended by 
Statistical Guidelines for the analysis of data obtained from 
one or both eyes.14
This study was approved by the local ethics committee 
of Centro Hospitalar do Porto, EPE. All patients provided 
informed consent to use their medical records.
In these patients, Intacs and Intacs SK (Addition 
 Technology Inc.) ICRS were used. The surgeries were 
performed by three corneal surgeons, using a standard tech-
nique of tunnel creation by mechanical dissection. ICRS 
were implanted according to a preoperative plan and an 
implantation nomogram provided by the manufacturers of 
Intacs ICRS.
The demographic data, follow-up time, preoperative 
and postoperative uncorrected visual acuity (UCVA) and 
BCVA in decimal scale were evaluated. Corneal topogra-
phy and thickness were obtained at preoperative visit and at 
6–12 months, 24–36 months, and at the last visit (≥5 years 
postoperative) using the Bausch & Lomb’s Orbscan® IIz.
Statistical analysis was done using SPSS for windows 
(version 24; SPSS Inc., Chicago, IL, USA). After check-
ing the normality of data using the Shapiro–Wilk test, the 
Wilcoxon rank-sum test was used to compare preoperative 
and postoperative parameters. As the analysis was performed 
at four time points, the Bonferroni correction was applied. 
Therefore, statistical significance was established at p<0.0125 
(two-sided).
Results
Fourteen eyes of 14 patients were included in this study. The 
mean age of patients at the time of surgery was 15.36±2.84 
years (range 10–18 years old), with 64.3% being males 
and 35.7% females. All patients had been diagnosed with 
keratoconus with reported progression in the 6 months prior 
to surgery. All procedures were uneventful. Intacs SK were 
implanted in four eyes, while conventional Intacs were used 
in 10 eyes (Figure 1). In seven eyes, single-segment Intacs 
were implanted. Follow-up time was 6.36±0.97 years.
In one case, ICRS extrusion occurred 7 months after sur-
gery spontaneously. As the patient remained with satisfactory 
visual acuity (BCVA 0.6 in decimal scale) and no significant 
progression was observed, corneal transplantation was not 
performed. During the considered follow-up, there were no 
other complications to report.
Baseline average UCVA and BCVA were 0.07±0.09 and 
0.34±0.21, respectively, and they improved to 0.25±0.15 and 
0.54±0.17 after ICRS implantation (p<0.01 and p=0.011, 
respectively). During follow-up, both UCVA and BCVA 
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remained almost constant, reaching, at the end of follow-up, 
0.3±0.21 and 0.55±0.13 without statistically significant dif-
ferences from those observed at 6–12 months postoperatively, 
(Tables 1 and 2).
Central corneal thickness remained stable after the 
surgery, ranging from 416.43±47.38 to 409.75±54 μm 
6–12 months after surgery (p=0.14). K minimum (Kmin) 
decreased from 48.9±3.25 to 45.29±3.45 D (p=0.001) and 
K maximum (Kmax) reduced from 55.92±4.56 to 51.4±3.33 
D (p=0.002) 6–12 months after surgery. During follow-up, 
Kmin and Kmax values ranged (Table 1), showing a tendency 
to increase at the end of follow-up. However, statistically 
significant differences were not observed (Table 3).
Until the end of follow-up, no patient needed additional 
procedures, besides the use of optical correction with glasses 
or contact lenses.
Discussion
Keratoconus typically presents in teenagers and progresses 
until the third or fourth decade.2 The disease behavior is 
different in pediatric patients when compared with adults, 
since it may present at more aggressive stage and progress 
more rapidly.3,15 These aspects make the disease manage-
ment in this age very challenging. Contact lenses may not 
be well tolerated and, despite the introduction of lamellar 
transplantation techniques and the better visual outcomes 
and graft survival in patients with keratoconus than in grafts 
performed for other indications, corneal transplantation in 
pediatric patients can be associated with higher incidence 
of complications.16–18 Treatments such as corneal collagen 
cross-linking and ICRS should be considered in this age. 
In a meta-analysis, McAnena et al showed that standard 
corneal collagen cross-linking seems to be effective in halt-
ing the progression of keratoconus in pediatric patients.19 
However, concerning ICRS implantation in these popula-
tion, studies are lacking. Although some studies included 
younger patients and some suggested that they can halt the 
progression of keratoconus, the authors found no study 
including only pediatric patients or patients <15 years. 
These are the reasons why, in our study, we intended to 
evaluate the long-term outcomes of ICRS implantation in 
pediatric patients.
Since the first report of ICRS implantation outcomes 
for the treatment of keratoconus, several authors have 
demonstrated the efficacy of this technique in improving 
keratometric readings in this disease. ICRS implantation 
leads to a flattening of the central cornea and regularization 
of the asymmetry of the tissue, resulting in a reduction of 
keratometric readings, with a mean reduction between 3 and 
5 D.20–23 In addition, the majority of these studies report a gain 
in both the uncorrected and best-corrected visual acuities. 
Similar to the cited studies, in our study we observed an 
improvement of keratometric values, UCVA, and BCVA after 
ICRS implantation. Kmax and Kmin decreased, on average, 
Figure 1 Implanted ICRS at the end of follow-up.
Notes: (A) Implanted Intacs® ICRS. (B) Implanted Intacs SK ICRS.
Abbreviations: ICRS, intracorneal ring segments; SK, severe keratoconus.
A B
Table 1 Visual outcomes and keratometry readings before and after ICRS implantation
Variable Preoperative 6–12 months 
postoperative
24–36 months 
postoperative
>60 months  
postoperative
UCVA (range) 0.07±0.09 (0.01–0.32) 0.25±0.15 (0.05–0.5) 0.3±0.2 (0.05–0.5) 0.3±0.21 (0.05–0.5)
BCVA (range) 0.34±0.21 (0.05–0.63) 0.54±0.17 (0.3–0.8) 0.56±0.1 (0.4–0.8) 0.55±0.13 (0.4–0.8)
Central corneal thickness (μm), range 416.43±47.38 (335–494) 409.75±54 (356–472) 410.45±43.44 (335–475) 412.56±47.18 (338–485)
K minimum (D) (range) 48.9±3.25 (43.2–52.9) 45.29±3.45 (37.4–51.4) 46.34±3.45 (38.2–51.3) 46.38±3.42 (38–51.4)
K maximum (D) (range) 55.92±4.56 (47.5–62.4) 51.4±3.33 (46.7–56.8) 51.65±3.71 (46.4–56.0) 52.19±3.60 (47.3–57.2)
Abbreviations: BCVA, best-corrected visual acuity; D, diopters; ICRS, intracorneal ring segments; K, keratometry; UCVA, uncorrected visual acuity.
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3.59 and 3.18 D, respectively, which agree with the values 
observed in previous studies.
As noted earlier, in our patients we used Intacs ICRS, 
both conventional and SK. We did not analyze differences 
between these two devices since we had a small sample and 
previous reports showed that implantation of conventional 
and SK Intacs had comparable outcomes.24,25 Also, we did 
not study differences between using single- or double-
segment implantation. In literature, some authors claim that 
single-segment implantation provides better results,26 while 
others claim that the results vary with topographic pattern 
of keratoconus27 or with spherical equivalent to correct.28,29 
As there are several factors that can influence the selection 
of one or two segments and since our sample is small, we 
decided not to evaluate these outcomes.
In the matter of the stability of the results of ICRS implan-
tation in long-term follow-up, we found contradictory results 
in the literature. While some authors report long-term stabil-
ity of surgical results, Vega-Estrada et al23,30 and Alió et al31 
observed that the long-term stability of ICRS implantation 
depends on the progression pattern of keratoconus at the time 
of surgery, suggesting that in cases of stable keratoconus the 
results remained stable, in opposition to progressive disease 
where the short-term outcomes could change after a long 
period of time. In our study, we observed, in fact, changes in 
keratometric readings over time. However, these differences 
were not statistically significant. In our study, the fact that, 
the included patients were aged between 10 and 18 years 
with a great temporal edge of disease progression may be 
the reason for not getting statistically significant differences 
in keratometric readings over time. Regarding visual acuity, 
we observed maintenance of the visual gains achieved with 
ICRS implantation. Thus, once our results suggest that ICRS 
implantation does not halt progression of keratoconus over 
time, it is important to consider the use of alternative treat-
ments or combination of different treatment modalities in 
the management of pediatric keratoconus.
Conclusion
ICRS implantation shows good visual and topographic results 
in pediatric patients. Although not statically significant, 
long-term follow-up of these patients suggests that ICRS 
implantation does not halt the progression of keratoconus.
To the best of the authors’ knowledge, this is the first 
study that evaluates the effect of ICRS implantation in such 
young patients and with such a long follow-up.
Table 2 Visual outcomes during follow-up
Variable Compared period Compared values p-value
UCVA Preoperative vs 6–12 months postoperative 0.07±0.09 vs 0.25±0.15 0.008
Preoperative vs >60 months postoperative 0.07±0.09 vs 0.3±0.21 0.009
6–12 months vs 24–36 months postoperative 0.25±0.15 vs 0.3±0.2 0.115
24–36 months vs >60 months postoperative 0.3±0.2 vs 0.3±0.21 0.970
6–12 months vs >60 months postoperative 0.25±0.15 vs 0.3±0.21 0.115
BCVA Preoperative vs 6–12 months postoperative 0.34±0.21 vs 0.54±0.17 0.011
Preoperative vs >60 months postoperative 0.34±0.21 vs 0.55±0.13 0.010
6–12 months vs 24–36 months postoperative 0.54±0.17 vs 0.56±0.1 0.831
24–36 months vs >60 months postoperative 0.56±0.1 vs 0.55±0.13 0.986
6–12 months vs >60 months postoperative 0.54±0.17 vs 0.55±0.13 0.944
Abbreviations: BCVA, best-corrected visual acuity; UCVA, uncorrected visual acuity.
Table 3 Keratometry changes after ICRS implantation
Variable Compared period Compared values p-value
K Maximum Preoperative vs 6–12 months postoperative 55.92±4.56 vs 51.4±3.33 0.002
Preoperative vs >60 months postoperative 55.92±4.56 vs 52.19±3.60 0.004
6–12 months vs 24–36 months postoperative 51.4±3.33 vs 51.65±3.71 0.504
24–36 months vs >60 months postoperative 51.65±3.71 vs 52.19±3.60 0.058
6–12 months vs >60 months postoperative 51.4±3.33 vs 52.19±3.60 0.074
K Minimum Preoperative vs 6–12 months postoperative 48.9±3.25 vs 45.29±3.45 0.001
Preoperative vs >60 months postoperative 48.9±3.25 vs 46.38±3.42 0.003
6–12 months vs 24–36 months postoperative 45.29±3.45 vs 46.34±3.45 0.053
24–36 months vs >60 months postoperative 46.34±3.45 vs 46.38±3.42 0.317
6–12 months vs >60 months postoperative 45.29±3.45 vs 46.38±3.42 0.052
Abbreviations: ICRS, intracorneal ring segments; K, keratometry.
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